Showing results (11-20 of 24) with videos related to
Sort By:
Pageof 3
Scientific Reports|September 17, 2020
Identification of serum IFN-α and IL-33 as novel biomarkers for type 1 autoimmune pancreatitis and IgG4-related diseaseKosuke Minaga, Tomohiro Watanabe, Akane Hara, et al.Biochemical and Biophysical Research Communications|November 20, 2022
High-fat diet aggravates experimental autoimmune pancreatitis through the activation of type I interferon signaling pathwaysIkue Sekai, Kosuke Minaga, Akane Hara, et al.Clinical and Experimental Immunology|May 13, 2022
Expression levels of cellular inhibitor of apoptosis proteins and colitogenic cytokines are inversely correlated with the activation of interferon regulatory factor 4Sho Masaki, Tomohiro Watanabe, Yasuyuki Arai, et al.Frontiers in Oncology|June 14, 2021
Case Report: Concurrent Occurrence of Abdominal Double Expressor Lymphoma and Jejunum Follicular LymphomaRyutaro Takada, Tomohiro Watanabe, Ikue Sekai, et al.International Immunology|August 31, 2022
Disruption of the intestinal barrier exacerbates experimental autoimmune pancreatitis by promoting the translocation of Staphylococcus sciuri into the pancreasTomoe Yoshikawa, Kosuke Minaga, Akane Hara, et al.Clinical and Experimental Immunology|September 8, 2025
Vitamin A deficiency enhances susceptibility to experimental autoimmune pancreatitis through activation of CD4+ T cells expressing CXCR3 and secreting CCL25Masayuki Kurimoto, Tomohiro Watanabe, Yasuo Otsuka, et al.Asian Pacific Journal of Allergy and Immunology|July 11, 2021
Immunohistochemical characterization of granulomatosis with polyangiitis exhibiting spontaneous regressionYasuhiro Masuta, Yoriaki Komeda, Ikue Sekai, et al.Internal Medicine (Tokyo, Japan)|July 16, 2025
Complete Remission of Acute-onset Autoimmune Hepatitis Following Transcatheter Splenic Arterial Embolization and Splenectomy for Spontaneous Splenic RuptureIkue Sekai, Masahiro Takita, Shigenobu Yasuhara, et al.Frontiers in Medicine|May 31, 2021
Case Report: A Case of Intestinal Behçet's Disease Exhibiting Enhanced Expression of IL-6 and Forkhead Box P3 mRNA After Treatment With InfliximabKeisuke Yoshikawa, Tomohiro Watanabe, Ikue Sekai, et al.Clinical and Experimental Immunology|May 11, 2023
Activation of the aryl hydrocarbon receptor inhibits the development of experimental autoimmune pancreatitis through IL-22-mediated signaling pathwaysKen Kamata, Akane Hara, Kosuke Minaga, et al.Pageof 3